微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 3.46% | 6.82% | 39.67% | 77/158 | 4.06% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.48% | -7.62% | 206.31% | 71/158 | 2.54% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.81% | 17.59% | -80.18% | 95/158 | 2.29% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 4.08% | 9.68% | 25.97% | 69/158 | -1.07% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 3.24% | -25.96% | 20.79% | 88/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.68% | -7.81% | 289.89% | 72/158 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.69% | 4.28% | -81.51% | 104/158 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 3.72% | 51.84% | -14.96% | 85/158 | 0.75% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 4.37% | 24.83% | 50.41% | 71/158 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.91% | 16.22% | 340.99% | 72/158 | 2.26% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.66% | 17.04% | -73.08% | 101/158 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 2.45% | 8.41% | -30.09% | 96/158 | 0.86% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 3.5% | 13.36% | 40.03% | 89/158 | 4.52% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.5% | 31.79% | 344.1% | 88/158 | 2.98% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.56% | 65.69% | -75.07% | 103/158 | 2.5% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 2.26% | 83.74% | -26.89% | 99/158 | 3.68% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 3.09% | 16.64% | 62.8% | 84/158 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 1.9% | 155.87% | 458.31% | 87/158 | 4.25% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.34% | -45.41% | -72.35% | 80/158 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 1.23% | -64.04% | -53.59% | 114/158 | 2.77% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 2.65% | -8.66% | 257.14% | 88/158 | 7.65% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 0.74% | -67.59% | 19.12% | 102/158 | 5.07% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.62% | 26.88% | -81.78% | 91/158 | 2.47% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 3.42% | 40.16% | 17.87% | 101/158 | 7.11% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 2.9% | 25.72% | 26.74% | 85/158 | 7.24% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 2.29% | 45.65% | 366.27% | 77/158 | 4.61% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.49% | 98.22% | -79.88% | 92/158 | 2.58% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 2.44% | 62.67% | 5.72% | 105/158 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 2.31% | -35.93% | 46.83% | 85/158 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.57% | -40.51% | 534.6% | 85/158 | 5.6% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.25% | 14.46% | -83.49% | 80/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 1.5% | -30.23% | -58.36% | 97/158 | 7.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 3.6% | 30.84% | 36.31% | 65/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 2.64% | 101.55% | 1121.12% | 61/158 | 3.86% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.22% | -20.56% | -89.93% | 73/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 2.15% | 416.18% | -21.9% | 85/158 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 2.75% | -29.05% | 109.98% | 59/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 1.31% | 91.63% | 381.31% | 63/158 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 0.27% | 135.68% | 140.06% | 65/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |
| 2014-12-31 | -0.68% | -183.95% | -117.52% | 94/158 | 12.37% | 广生堂 | 15.57% | 行业排名> |
| 2014-09-30 | 3.88% | 94.59% | 467.14% | 45/158 | 7.53% | 退市金泰 | 97.4% | 行业排名> |
| 2014-06-30 | 0.68% | 340.15% | 189.61% | 59/158 | -4.93% | 奥翔药业 | 93.52% | 行业排名> |
| 2014-03-31 | -0.76% | -137.04% | -194.26% | 64/158 | 2.13% | 退市金泰 | 47.24% | 行业排名> |